| Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy A Moreau, JB Reisqs, H Delanoe‐Ayari, M Pierre, A Janin, A Deliniere, ... Clinical and translational medicine 11 (3), e319, 2021 | 19 | 2021 |
| The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy JB Reisqs, A Moreau, A Charrabi, Y Sleiman, AC Meli, G Millat, V Briand, ... Clinical and Translational Medicine 12 (3), 2022 | 12 | 2022 |
| Spironolactone as a potential new treatment to prevent arrhythmias in arrhythmogenic cardiomyopathy cell model JB Reisqs, A Moreau, Y Sleiman, A Charrabi, A Delinière, F Bessière, ... Journal of Personalized Medicine 13 (2), 335, 2023 | 4 | 2023 |
| Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells JB Reisqs, A Moreau, Y Sleiman, M Boutjdir, S Richard, P Chevalier Frontiers in Physiology 14, 1191965, 2023 | 2 | 2023 |
| Ion channel trafficking implications in heart failure JB Reisqs, YS Qu, M Boutjdir Frontiers in Cardiovascular Medicine 11, 1351496, 2024 | | 2024 |
| Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1 VKM Ginjupalli, M Cupelli, JB Reisqs, Y Sleiman, N El-Sherif, G Gourdon, ... Frontiers in Physiology 14, 1257682, 2023 | | 2023 |
| Développement et caractérisation d’un modèle cellulaire cardiaque humain de cardiomyopathie arythmogène JB Reisqs Université de Lyon, 2022 | | 2022 |
Philippe ChevalierHospices Civils de Lyon, Université de LyonVerified email at chu-lyon.fr
